Common (1% to 10%): Upper respiratory tract infection, respiratory infection, bronchitis, pharyngitis, sinusitis, nasopharyngitis, coughCandesartan:Frequency not reported: Cough, rhinitisHydrochlorothiazide:Frequency not reported: Pneumonitis, pulmonary edema
Common (1% to 10%): Hypokalemia, dyslipidemiaUncommon (0.
1% to 1%): HyperkalemiaCandesartan:Very rare (less than 0.
01%): Hyponatremia, hyperkalemiaHydrochlorothiazide:Frequency not reported: Anorexia, loss of appetite, hyperglycemia, hyperuricemia, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased
Common (1% to 10%): Abdominal pain, nauseaUncommon (0.
1% to 1%): VomitingCandesartan:Frequency not reported: DiarrheaHydrochlorothiazide:Frequency not reported: Gastric irritation, diarrhea, constipationPostmarketing reports: Sialadenitis, cramping
Common (1% to 10%): Influenza-like symptoms, inflicted injuryFrequency not reported: FatigueCandesartan:Frequency not reported: Peripheral edemaHydrochlorothiazide:Frequency not reported: Fever, weakness, vertigo
Common (1% to 10%): Dizziness, headacheCandesartan:Postmarketing reports: SomnolenceHydrochlorothiazide:Frequency not reported: Lightheadedness, paresthesia
Common (1% to 10%): TachycardiaUncommon (0.
1% to 1%): Atrioventricular blockCandesartan:Postmarketing reports: PalpitationsHydrochlorothiazide:Frequency not reported: Vasculitis, postural hypotension, cardiac arrhythmias
Common (1% to 10%): Back painPostmarketing reports: MyalgiaCandesartan:Postmarketing reports: RhabdomyolysisHydrochlorothiazide:Frequency not reported: Muscle spasm
Common (1% to 10%): Urinary tract infectionHydrochlorothiazide:Frequency not reported: GlycosuriaPostmarketing reports: Impotence
Candesartan:Very rare (less than 0.
01%): Angioedema, urticaria, pruritus, rashHydrochlorothiazide:Frequency not reported: Photosensitivity reactions, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, urticaria, cutaneous vasculitis, toxic epidermal necrolysisPostmarketing reports: Purpura, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, alopecia
Candesartan:Very rare (less than 0.
01%): Leucopenia, neutropenia, agranulocytosisHydrochlorothiazide:Frequency not reported: Leucopenia, neutropenia, agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, bone marrow depression
Candesartan:Very rare (less than 0.
01%): Liver enzymes increased, abnormal hepatic function, hepatitisHydrochlorothiazide:Frequency not reported: Intrahepatic cholestatic jaundice, pancreatitis
Candesartan:Very rare (less than 0.
01%): Renal impairment, renal failureHydrochlorothiazide:Frequency not reported: BUN increased, serum creatinine increased, renal dysfunction, interstitial nephritis
Candesartan:Postmarketing reports: Agitation, anxiety, depression, insomnia, nervousness, sleep disorder, nightmareHydrochlorothiazide:Frequency not reported: Restlessness, sleep disturbances, depression
Hydrochlorothiazide:Frequency not reported: Transient blurred vision, acute myopia, acute angle-closure glaucoma, xanthopsia
Hydrochlorothiazide:Frequency not reported: Anaphylactic reactions
Cough
dizziness
dryness of the mouth
fever
increased thirst
irregular heartbeat
lightheadedness
muscle cramps
nausea
sore throat
unusual tiredness
vomiting
weak pulse
weakness
Arm pain
chest pain
chest tightness
fast or irregular heartbeat
large, hive like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
shortness of breath
Back pain
diarrhea
headache
joint pain
loss of appetite
muscle aches and pains
runny nose
sneezing
sweating
trouble sleeping